Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FA0ZD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,277
Award facts
- Contract value 100% obligated
- $62,276.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $62,276.90, was awarded on January 5, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injector pens. The award is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 6, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
Repatha is a prescription medication used for cholesterol management and cardiovascular disease prevention, making this procurement consistent with the Defense Health Agency's pharmaceutical supply requirements for military personnel and beneficiaries. The delivery order reflects AmerisourceBergen Drug Corp's established role as a primary pharmaceutical vendor within the DLA's medical supply chain, where the company maintains a substantial portfolio of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The firm fixed-price structure and competitive award underscore the company's demonstrated capability to meet federal procurement standards and deliver specialized pharmaceutical products efficiently to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FA0ZD?
SPE2DR26FA0ZD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FA0ZD worth?
The government has obligated $62,277 on SPE2DR26FA0ZD.
Is contract SPE2DR26FA0ZD an order under another contract?
Yes. SPE2DR26FA0ZD is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0ZD competed?
The extent of competition for SPE2DR26FA0ZD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award